North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market By Surgery (Glaucoma in Conjunction with Cataract, Stand Alone Glaucoma), Target (Trabecular Meshwork, Suprachoroidal Space), Product (Stents, Shunts), End User (Eye Hospitals, Ophthalmology Clinics)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Surgery
1.4.2 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Target
1.4.3 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Product
1.4.4 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by End User
1.4.5 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.2 Drivers, and Restraints
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
3.1.1 North America Glaucoma in Conjunction with Cataract Market by Country
3.1.2 North America Stand Alone Glaucoma Market by Country
Chapter 4. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
4.1.1 North America Trabecular Meshwork Market by Country
4.1.2 North America Suprachoroidal Space Market by Country
4.1.3 North America Other Targets Market by Country
Chapter 5. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
5.1.1 North America MIGS Stents Market by Country
5.1.2 North America MIGS Shunts Market by Country
5.1.3 North America Other Products Market by Country
Chapter 6. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
6.1.1 North America Eye Hospitals Market by Country
6.1.2 North America Ophthalmology Clinics Market by Country
6.1.3 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices in Other End User Market by Country
Chapter 7. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country
7.1 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.1.1 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.1.2 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.1.3 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.1.4 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.2 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.2.1 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.2.2 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.2.3 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.2.4 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.3 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.3.1 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.3.2 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.3.3 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.3.4 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.4 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.4.1 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.4.2 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.4.3 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.4.4 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
Chapter 8. Company Profile
8.1 Ellex Medical Lasers Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Allergan Plc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.3 Santen Pharmaceutical Co., Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Glaukos Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Novartis AG (Alcon Inc.)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Lumenis Ltd.
8.6.1 Company Overview
8.7 iSTAR Medical
8.7.1 Company Overview
8.8 Ivantis, Inc.
8.8.1 Company Overview
8.9 SOLX, Inc.
8.9.1 Company Overview